<?xml version="1.0" encoding="UTF-8"?><!-- This information is licensed under the Queen's Printer License of British Columbia found: www.bclaws.ca/standards/2014/QP-License_1.0.html. Please review the license terms carefully. --><reg_pit xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:reg="http://www.gov.bc.ca/2013/legislation/regulation" xmlns:bcl="http://www.gov.bc.ca/2013/bclegislation" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:in="http://www.qp.gov.bc.ca/2013/inline" xmlns:fun="http://www.bclaws.ca/xslt/functions" xmlns:act="http://www.gov.bc.ca/2013/legislation/act" xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table" xsi:noNamespaceSchemaLocation="https://styles.qp.gov.bc.ca/media/REGS-PIT-XSD.xsd" id="417_2008_pit">
  <acttitle>Health Professions Act</acttitle>
  <title>Pharmacists Regulation</title>
  <regnum>417/2008</regnum>
  <change section="1">
    <changenote eff="October 9, 2009">Section 1 definition of "practice of pharmacy", paragraph (a.1) was added by BC Reg <amendingreg>234/2009</amendingreg>, effective October 9, 2009.</changenote>
    <changenote eff="October 9, 2009">Section 1 definition of "substance" was added by BC Reg <amendingreg>234/2009</amendingreg>, effective October 9, 2009.</changenote>
  </change>
  <change>
    <changenote eff="July 26, 2016">Section 1 definition of "medical assistance in dying" was added by BC Reg <amendingreg>201/2016</amendingreg>, effective July 26, 2016.</changenote>
  </change>
  <change>
    <changenote eff="June 1, 2023">Section 1 definition of "practice of pharmacy", paragraph (a.1) BEFORE amended by BC Reg <amendingreg>111/2023</amendingreg>, effective June 1, 2023.</changenote>
    <bcl:paragraph id="d2e165">
      <bcl:num>a.1</bcl:num>
      <bcl:text>promoting health and preventing diseases, disorders and conditions through drug therapy,</bcl:text>
    </bcl:paragraph>
    <changenote eff="June 1, 2023">Section 1 definition of "substance" BEFORE amended by BC Reg <amendingreg>111/2023</amendingreg>, effective June 1, 2023.</changenote>
    <bcl:definition id="d2e217">
      <bcl:text>
        <in:term>substance</in:term> means a drug that is not specified in Schedule I, IA, II or IV of the Drug Schedules Regulation.</bcl:text>
    </bcl:definition>
  </change>
  <change section="2">
    <changenote eff="January 1, 2011">Section 2 (e) was added by BC Reg <amendingreg>211/2010</amendingreg>, effective January 1, 2011.</changenote>
  </change>
  <change section="4">
    <changenote eff="October 9, 2009">Section 4 (1) (c.1) was added by BC Reg <amendingreg>234/2009</amendingreg>, effective October 9, 2009.</changenote>
  </change>
  <change>
    <changenote eff="October 30, 2009">Section 4 (1) (c.1) BEFORE amended by BC Reg <amendingreg>256/2009</amendingreg>, effective October 30, 2009.</changenote>
    <paragraph>
      <paragraphnumber>c.1</paragraphnumber>
      <paragraphtext>in respect of a drug specified in Schedule I, IA or II of the Drug Schedules Regulation or a substance,</paragraphtext>
    </paragraph>
    <subparagraph>
      <subparagraphnumber>i</subparagraphnumber>
      <subparagraphtext>administer the drug or substance by intramuscular or subcutaneous injection, or</subparagraphtext>
    </subparagraph>
    <subparagraph>
      <subparagraphnumber>ii</subparagraphnumber>
      <subparagraphtext>administer the drug or substance by any method for the purpose of treating anaphylaxis arising from administering a drug or substance by intradermal, intramuscular or subcutaneous injection, as described in subparagraph (i);</subparagraphtext>
    </subparagraph>
  </change>
  <change>
    <changenote eff="December 3, 2015">Section 4 (1) (c.1) (i) and (ii) BEFORE amended by BC Reg <amendingreg>225/2015</amendingreg>, effective December 3, 2015.</changenote>
    <bcl:subparagraph id="d2e357">
      <bcl:num>i</bcl:num>
      <bcl:text>administer the drug or substance by intradermal, intramuscular or subcutaneous injection, or</bcl:text>
    </bcl:subparagraph>
    <bcl:subparagraph id="d2e366">
      <bcl:num>ii</bcl:num>
      <bcl:text>administer the drug or substance by any method for the purpose of treating anaphylaxis arising from administering a drug or substance by intradermal, intramuscular or subcutaneous injection, as described in subparagraph (i);</bcl:text>
    </bcl:subparagraph>
  </change>
  <change>
    <changenote eff="June 1, 2023">Section 4 (1) (a), (b) and (c) BEFORE amended by BC Reg <amendingreg>111/2023</amendingreg>, effective June 1, 2023.</changenote>
    <bcl:paragraph id="d2e320">
      <bcl:num>a</bcl:num>
      <bcl:text>prescribe a drug specified in Schedule IV of the Drug Schedules Regulation to be used for emergency contraception;</bcl:text>
    </bcl:paragraph>
    <bcl:paragraph id="d2e329">
      <bcl:num>b</bcl:num>
      <bcl:text>compound a drug specified in Schedule I, IA, II or IV of the Drug Schedules Regulation;</bcl:text>
    </bcl:paragraph>
    <bcl:paragraph id="d2e339">
      <bcl:num>c</bcl:num>
      <bcl:text>dispense a drug specified in Schedule I, IA, II or IV of the Drug Schedules Regulation;</bcl:text>
    </bcl:paragraph>
    <changenote eff="June 1, 2023">Section 4 (a.1) and (a.2) were added by BC Reg <amendingreg>111/2023</amendingreg>, effective June 1, 2023.</changenote>
  </change>
  <change section="4.1">
    <changenote eff="October 9, 2009">Section 4.1 was enacted by BC Reg <amendingreg>234/2009</amendingreg>, effective October 9, 2009.</changenote>
  </change>
  <change>
    <changenote eff="July 26, 2016">Section 4.1 was renumbered as section 4.1 (1) and (2) was added by BC Reg <amendingreg>201/2016</amendingreg>, effective July 26, 2016.</changenote>
  </change>
  <change>
    <changenote eff="June 1, 2023">Section 4.1 (1) was renumbered as section 4.1 (1.1) and (1) was added by BC Reg <amendingreg>111/2023</amendingreg>, effective June 1, 2023.</changenote>
  </change>
  <change schedule="A">
    <changenote eff="June 1, 2023">Schedule A was enacted by BC Reg <amendingreg>111/2023</amendingreg>, effective June 1, 2023.</changenote>
  </change>
</reg_pit>